CEFEXICLAV

This brand name is authorized in Nigeria.

Active ingredients

The drug CEFEXICLAV contains a combination of these active pharmaceutical ingredients (APIs):

1	Cefixime UNII 97I1C92E55 - CEFIXIME
	Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.
	Read more about Cefixime
2	Clavulanic acid UNII Q42OMW3AT8 - CLAVULANATE POTASSIUM
	Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
	Read more about Clavulanic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6581	Tablet	CEFEXICLAV 325 TABLETS TAB 200 mg; 125 mg 1 X 10	150 CMS-PP-233269 CEFEXICLAV 325 TABLETS CEFIXIME 200MG, CLAVULANIC ACID 125MG Cefixime BP (As Trihydrate Eq. to Anhydrous Cefixime 200 mg, Clavulanate Potassium BP Eq. to Anhydrous Clavulanic Acid 25 mg, Lactose Monohydrate, Microcrystalline Cellulose, Croscarmellose Sodium, Colloidal Anhydrous Silica (Aerosil), Pregelatinized Starch, Purified Talc, Magnesium Stearate B4-6581 Drugs Imported Products 110 Prescription Only Medicine (POM) 10/5/2021 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India	06/07/2023
B4-6583	Suspension	CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML SUSP 50 mg/5 mL; 31.25 mg/5 mL 1X100ML	149 CMS-PP-233255 CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML CEFIXIME 50MG + CLAVULANIC ACID 31.25MG Cefixime Trihydrate Eq to Cefixime (A) 50mg, Diluted Potassium Clavulanate Eq. to Clavulanic Acid (A) 31.25mg, Sucrose (D)$ 937mg, Colloidal Anhydrous Silica 15mg, Carmellose Sodium (Sodium Carboxymethylcellulose) 25mg, Sodium Citrate 11.25mg, Sodium Benzoate 1.04mg, Essence Orange Powder (Firemenich) 13.10mg, Aspartame 6.360mg, Disodium Edetate 10mg B4-6583 Drugs Imported Products 1100ML Prescription Only Medicine (POM) 10/5/2021 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD08	Cefixime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6581, B4-6583